Synthesis and Monoamine Oxidase Inhibitory Activity of Halogenated Flavones

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Biochemistry

Background:

• Monoamine oxidase (MAO) metabolizes neurotransmitters, and its inhibitors treat neurological disorders.
• Monoamine oxidase inhibitors (MAOIs) are crucial for managing conditions like depression.
• Flavonoids, like acacetin, are dietary compounds with potential therapeutic applications.

Purpose of the Study:

• To design and synthesize novel halogenated flavonoids as selective monoamine oxidase-B (MAO-B) inhibitors.
• To evaluate the inhibitory activity of these compounds against MAO-A and MAO-B.
• To explore the potential of these compounds as therapeutic agents for neurological disorders.

Main Methods:

• Synthesis of 36 halogenated flavones with fluorine or chlorine at positions 5 and 7.
• In vitro enzymatic assays to determine MAO-A and MAO-B inhibition.
• Determination of IC50 values for selective MAO-B inhibition.

Main Results:

• All synthesized compounds demonstrated selectivity for MAO-B inhibition.
• Compounds exhibited potent MAO-B inhibitory activity with IC50 values in the micro- and nanomolar range.
• Specific compounds (9f, 10a-c, 11a-c, 11g,h, 11l) showed IC50 values between 16-74 nM.

Conclusions:

• Halogenated flavonoids are effective selective MAO-B inhibitors.
• These compounds represent a promising scaffold for developing new treatments for neurological disorders.
• Further research into halogenated flavonoids could lead to novel therapeutic agents.